| pubmed-article:9617106 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9617106 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9617106 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:9617106 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9617106 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:9617106 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
| pubmed-article:9617106 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9617106 | pubmed:dateCreated | 1998-7-10 | lld:pubmed |
| pubmed-article:9617106 | pubmed:abstractText | Immunosuppressive approaches to combined kidney-pancreas tx include quadruple therapy with either antilymphocyte globulin (ATG) or OKT3 for a short period (7-14 days) immediately after transplantation. Maintenance therapy with prednisone, azathioprine and cyclosporin is then used to ensure the long-term survival of the graft. This study reports 23 cases of combined kidney-pancreas tx under ATG induction (n = 7) and OKT3 induction (n = 16). Both groups had maintenance therapy with azathioprine, prednisone and cyclosporin. The follow-up was 12 months. Graft loss was 3 out of 7 vs 1 out of 16 (p < 0.05) for the kidney and 3 out of 7 vs 3 out of 16 for the pancreas in ATG treated vs OKT3 treated patients respectively. There were two deaths in the ATG group and one in the OKT3 group; two patients died with functioning graft, one in each group. The one year actuarial survival was 87% for graft and patient, 83% for kidney and 77% for pancreas. Combined kidney-pancreas tx with ATG or OKT3 have a similar outcome. OKT3 allows a longer period before the onset of rejection. There is a trend in survivals which suggests a better survival in OKT3 treated recipients. Infections and other complications were similar in ATG and OKT3 patients. | lld:pubmed |
| pubmed-article:9617106 | pubmed:language | ita | lld:pubmed |
| pubmed-article:9617106 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9617106 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9617106 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9617106 | pubmed:issn | 0026-4733 | lld:pubmed |
| pubmed-article:9617106 | pubmed:author | pubmed-author:KuoPP | lld:pubmed |
| pubmed-article:9617106 | pubmed:author | pubmed-author:KriegerNN | lld:pubmed |
| pubmed-article:9617106 | pubmed:author | pubmed-author:AlfreyE JEJ | lld:pubmed |
| pubmed-article:9617106 | pubmed:author | pubmed-author:DafoeD CDC | lld:pubmed |
| pubmed-article:9617106 | pubmed:author | pubmed-author:MaestreAA | lld:pubmed |
| pubmed-article:9617106 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9617106 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:9617106 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9617106 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9617106 | pubmed:pagination | 121-8 | lld:pubmed |
| pubmed-article:9617106 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:meshHeading | pubmed-meshheading:9617106-... | lld:pubmed |
| pubmed-article:9617106 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9617106 | pubmed:articleTitle | [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients]. | lld:pubmed |
| pubmed-article:9617106 | pubmed:affiliation | Department of Surgery, University of Stanford, USA. | lld:pubmed |
| pubmed-article:9617106 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9617106 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9617106 | pubmed:publicationType | English Abstract | lld:pubmed |
